Indian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading companies like Zydus, Cipla, Alkem, and Aurobindo Pharma are in discussions to supply the medicine. The US FDA has reached out to Indian pharmaceutical bodies, seeking manufacturers capable of producing the drug in various strengths to ensure availability for cancer patients.
RSS News
Economic times
0 thoughts on “Indian pharma firms gear up to supply key cancer drug to US”
Leave a Reply
Your email address will not be published. Required fields are marked *
RECENT NEWS
- Inside India’s language conundrum
- 'Team India is the best...', every Pakistani will feel chilly after hearing this statement of the PAK coach; Know what to say
- Sai Sudarshan and Devdutt Padikkal dominate the second day, Sri Lankan bowlers take their breath; Robbed by a century
- 'Indus Waters Treaty remains suspended': India rebukes Pakistan rhetoric, affirms key condition
- Kamikaze drones, anti-tank missiles among Rs 52,000 crore defence procurement proposals approved by DAC
